Based in Scottsdale, Arizona, Envita Medical Centers—founded by CEO Dr. Dino Prato—offers an innovative treatment approach that goes beyond standard conventional medicine. The team of integrative physicians, including oncologists, interventional radiologists, and other specialists, provide cancer treatment tailored to each patient’s needs. For over 20 years, Envita has successfully treated people with late-stage cancers who had not responded to standard therapies

Leveraging a century’s worth of combined medical experience, Envita Medical Centers employs precision oncology to target cancerous tissue. One Envita innovation is Chemo Immuno Precision Injection (CIPI™). This technique allows doctors to administer immunotherapy and chemotherapy medications directly into the tumor for targeted impact. Precise targeting helps to overcome the challenges of traditional standard treatments, in which chemo medications may affect adjoining healthy cells in the body, triggering serious side effects and increasing drug resistance

Guided by the vision of Dr. Dino Prato, Envita emphasizes highly personalized, integrative care. A significant portion of Envita's medications include custom compounded adjuvants to suit each individual patient. This approach to personalized medicine is based on advanced genetic testing, which helps guide tailored treatment protocols for addressing the root cause of the disease. Through the implementation of these personalized regimens, the Envita team has assisted patients facing advanced cancers, many of whom were recommended hospice care by other healthcare providers

Envita